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Objective. To assess the impact of an interactive activity on student pharmacists’ confidence in an-
swering oncology-related questions and their perceptions of an oncology pharmacists’ roles in practice.
Methods. Two cohorts (2016 and 2017) of third-year student pharmacists completed a two-hour,
interactive, four-station activity during the fourth week of an oncology module. Each station simulated
a different oncology-related scenario that represented a specific practice settings. Pre- and post-activity
surveys were administered to determine changes in students’ confidence levels and perceptions.
Results. Over the two years, 66 student pharmacists completed the pre- and post-activity survey
instruments. In both cohorts, there was a significant increase in scores on all items regarding students’
confidence. Student pharmacists’ perceptions of pharmacists’ roles also improved significantly.
Conclusion. The simulation activity was effective as confirmed by improvement in student pharma-
cists’ post-activity scores on confidence and perception. Determining student pharmacists’ comfort in
responding to oncology scenarios is important to prepare them for practice in any setting.
Keywords: oncology practice, student pharmacist, confidence, perception, chemotherapy
INTRODUCTION
Pharmacists’ roles in the care of oncology patients
are continually evolving as providers are challenged with
medication shortages, rapid availability of newly ap-
proved oncolytics (oral chemotherapy), high-cost thera-
pies, and reduced reimbursement.According to studies by
the American Society of Clinical Oncology, the demand
for oncology servicesmay rise disproportionately to other
services because of patient age distribution, provider
practice patterns, and the number of oncology fellowship
positions for medical graduates available in the United
States.1,2 Pharmacists are well-positioned to compensate
for the predicted shortage of providers in this area because
of their extensive pharmacology knowledge as well as the
postgraduate residency training and advanced specialty
certification available in this area.
Oncology pharmacists are responsible for compre-
hensive medication management; counseling patients;
developing therapeutic plans; evaluating drug therapies;
monitoring treatment-related toxicities; ensuring safe
compounding and preparation of chemotherapies, bio-
logics, and immunotherapy; and serving as an integral
member of oncology interdisciplinary teams.2 Pharma-
cists also influence formulary management and institu-
tional policies and standards.3 As treatment options
become more targeted toward tumor type, biomarkers,
andmutation expression, pharmacists can play a vital role
in therapy optimization. Pharmacy-led drug evaluation
can subsequently lead to decreased costs, prevention of
adverse events, and improved outcomes and quality of
life. Growing recognition of pharmacists’ value supports
the continual need for adequate training in oncology
pharmacotherapy to deliver quality patient care.3,4 To
achieve this, it is critical to prepare student pharmacists as
future practitioners equipped to address the provider gap
in oncology care.
There are few studies in the literature on the imple-
mentation of pharmacy oncology courses or advanced
pharmacy practice experiences (APPE) in oncology and
their impact on student pharmacists’ knowledge and
perceptions of oncology practice. In a study evaluating
the impact of an oncology elective course on student
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pharmacists’ interest in oncology practice, only 45 of 53
students completed two consecutive semesters of the
course. There was a decrease in the number of students
showing interest in pursuing oncology specialty residen-
cies or becoming board certified in oncology.5 Another
study examined the impact of a one-credit hour oncology
elective course on examination scores for a pharmaco-
therapeutics course between third-year student pharma-
cistswho took the oncology elective course and thosewho
did not. Students who took the elective had significantly
higher scores on three out of the six examinations. Stu-
dents also provided positive feedback and expressed an
increased interest in pursuing a career in oncology phar-
macy, with 35% agreeing that the course increased their
interest in oncology.6 In a third study evaluating the
impact of a comprehensive ovarian cancer case-based
simulation on knowledge in 109 third-year student phar-
macists, a significant improvement in knowledge was
seen as evidenced by higher scores on three of the six
items on the post-activity test compared to the pre-activity
test. The students’ perceptions of oncology pharmacists’
roles and students’ self-confidence in reviewing and dis-
pensing oncolytics also increased significantly.7 Another
study reported on an acute care oncology pharmacy
practice experience in a layered learning practice model
for APPE students, PGY1 residents, and PGY2 residents
to evaluate learner perception of the model and achieve-
ment of knowledge-based learning objectives. All post-
test scores significantly increased compared to pretest
scores, and learners viewed the experience as positive and
felt it allowed for improvement in clinical and self-man-
agement skills.8 Most of the studies discussed here
documented improvement in pharmacy students’ oncol-
ogy knowledge after implementation of an oncology
APPE or elective course and positive perceptions of on-
cology pharmacy practice; however, because these were
elective experiences, they only impacted those student
pharmacists who enrolled in the course.
There are a limited number of studies in the literature
that discuss student pharmacists’ perceptions about their
use of oncology knowledge once they are licensed phar-
macists. In a study published in 2017, researchers evalu-
ated Florida student pharmacists’ interests (N5532 from
five out of six schools of pharmacy) in oncology phar-
macy and areas of oncology specialization. Three-fourths
(75%) of students were only moderately comfortable or
not comfortable with oncology, while over half (56%) of
students expressed interest in pursuing oncology in their
future pharmacy practice. Most students reported no ac-
cess to oncology-related experiences, with less than five
students reporting having earned experiential hours re-
lated to oncology. They also requested additional
oncology experiential opportunities and elective courses.
Therefore, although some students showed interest in
learning more about or pursuing a career in oncology,
most students identified a perceived need for further
training in oncology topics.9
Although studies have been published that discuss
improvements in student pharmacists’ oncology knowl-
edge based on pre- and post-activity test scores and per-
ceptions of oncology practice at the end of interventions,
there are few studies that have evaluated student confi-
dence in their knowledge of oncology pharmacotherapy
and compared their perceptions of oncology practice be-
fore and after participating in interactive activities in a
required oncology module. We address these gaps in the
study presented here. The objectives of this study were
to assess students’ confidence in answering oncology-
related questions in different pharmacy practice settings
pre- and post-activity and students’ perceptions of the
importance of pharmacists in the treatment of cancer
patients prior to the course and after participating in the
interactive activity.
METHODS
This study was approved by the Institutional Review
Board (IRB) of Cedarville University. Two cohorts of
students (fall 2016 and fall 2017) were included.
Oncology was taught during a five-week module in
the fall of the third professional year. In the first profes-
sional (P1) year, students were introduced to pharmacist
roles and responsibilities through an integrated approach
between the didactic (Introduction to Pharmacy Practice
and Pharmacy Practice Laboratory courses) and the ex-
periential curriculum, which consisted of introductory
pharmacy practice experiences (IPPEs) in community
pharmacies. This was reinforced in the second profes-
sional year with IPPEs in the institutional setting. In the
oncology module, basic, clinical, and social and admin-
istrative sciences were integrated during the module, and
key oncologic, hematologic, and palliative care concepts
were included primarily through team-based learning
(TBL) pedagogy. Cases were also incorporated through-
out the module to reinforce concepts as part of TBL or
independently. Prior to beginning the module, students
had limited exposure to oncologic pharmacotherapy,
pathophysiology, and therapeutics, as well as limited
training in the pharmacist’s role in patient care, dispens-
ing, and medication safety. Based on feedback from stu-
dents, there was a gap in understanding of the importance
of having knowledge of oncology across practice settings.
To address this issue and reinforce the roles and respon-
sibilities of pharmacists introduced in the P1 year, a prior
































































chemotherapy checking activity was chosen to enhance
and provide students with a better idea of how oncology
impacts multiple practice settings.
A four-station activity was created to represent dif-
ferent practice settings: managed care, community phar-
macy, a hospital that does not have a clinical pharmacist
in oncology, and a hospital that does have a clinical phar-
macist in oncology. To create these stations, pharmacists
in each of these settingswere interviewed regarding their
roles and responsibilities with oncology-related medi-
cations. The information from those interviews was used
to create scenarios intended to highlight the responsi-
bilities of the pharmacists in each setting. Students then
practiced those responsibilities. In scenario 1 (managed
care), a cost-minimization research abstract was pro-
vided to students. Students used the information in the
article in addition to electronic drug information re-
sources to examine the cost and efficacy of an oncology
medication for formulary management. In scenario 2
(community pharmacy), a patient presented to the phar-
macy with adverse effects from chemotherapy (sleep
disturbances, constipation), and the students had to make
non-pharmacologic recommendations that did not interact
with the patient’s chemotherapy regimen. In scenario 3
(hospital without an oncology pharmacist), the students
had to determine the best course of action for a patient
presenting for cancer-related surgery who was enrolled in
an oncology clinical drug trial (when to discontinue the
medication,when to restart) and develop a communication
plan for the surgical team. In scenario 4 (hospital with
oncology pharmacist), students had to verify four pre-
scriptions, which required them to use their compounding
and calculations skills. Students completed the stations in
pre-assigned teams, and had 75 minutes to complete all
four stations. The last 30 minutes of the class was allotted
for a facilitator-led discussion of the students’ answers.
The activity tookplace inweek four of themodule during a
two-hour class session.
At this point in the curriculum, students had learned
the pharmacology of oncology medications as well as
about most major solid tumors. Thus, this activity was
intended to build on the prior knowledge they had gained
and solidify their understanding of the role of pharmacists
in various oncology settings. Students worked in pre-
assigned teams (five to six students per team), completed
each of the four stations, and then participated in a debrief.
The same faculty member (a social and administrative
sciences faculty member who also was a pharmacist with
experience as a community pharmacist and as a clinical
pharmacist in managed care) facilitated the activity for
both student cohorts, with a fourth professional year
student who was completing an advanced pharmacy
practice experience (APPE) co-facilitating. Students
could spend asmuch time as needed at each stationwithin
the designated 75minutes. The facilitators were available
for questions and led the debrief based on a key at the end
of the session.
To address the objectives, the same survey instru-
ment (17 items rated on a seven-point Likert-type) was
administered at the beginning of the oncology module
(pre-activity survey) and again immediately after students
completed the activity (post-activity survey). While
completion of the module itself would likely impact the
outcomes, the research teamwanted to identify changes in
student confidence and perceptions from the beginning of
the course to the end of the activity as the activity built
upon the knowledge and skills the students had developed
over the prior weeks. The survey had two separate as-
pects: the first nine items assessed students’ confidence in
answering oncology-related questions while the remain-
ing eight items assessed students’ level of agreement with
pharmacists’ involvement in oncology patient care. These
items were created by reviewing the literature and con-
ducting interviews with the pharmacists as described
above. Then, before implementation, the survey items
underwent review by the module coordinator (a clinical
oncology pharmacist) and a faculty member with survey
experience.
Statistical analysis was conducted using SPSS, v.
25.0 (IBM, Armonk, NY). A p-value of ,.05 was con-
sidered significant. As the data were not normally distrib-
uted,medianswere calculated for the pre- and post-activity
survey items. Changes in scores from pre- to post-activity
survey were assessed using a Wilcoxon signed rank test.
Differences between cohorts were assessed using a Mann-
Whitney U test. Descriptive statistics were performed for
all demographic items, including interquartile range (IQR,
spread of the 25th to 75th percentiles) for medians, and dif-
ferences between cohorts were assessed using a chi-square
or unpaired t test.
RESULTS
Sixty-six students (100% response rate) from two
cohorts completed pre- and post-activity surveys. There
were no significant differences in gender (p5.805), eth-
nicities (p5.163), and past oncology experience (p5.163)
between cohorts. However, student pharmacists in fall 2016
were significantly younger (23.3 years vs. 24.6 years,
p5.037; Table 1).
Students in both cohorts demonstrated significantly
more confidence in answering all nine oncology-related
questions in different pharmacy practice settings from
pre- and post-activity (Table 2). In both cohorts,
































































significant increases were seen between student phar-
macists’ pre- and post-activity median confidence scores
on all nine questions (p,.001). Students in the fall 2016
cohort had greater increases in confidence on four of
the nine survey questions than did students in the fall
2017 cohort.
Significant increases in students’ perceptions of the
importance of pharmacists in the treatment of cancer
patients pre- and post-activity occurred in both cohorts
(Table 2). In fall 2016, student pharmacists only exhibited
significantly higher levels of agreement (p,.05) on four
of the eight questions. Students in fall 2017 had significant
increases in scores on three of the same items as the 2016
cohort, but did not have significantly different scores on
the fourth item (managed care pharmacists being equip-
ped tomake chemotherapy formulary recommendations).
Similar increases in knowledge between the pre- and post-
activity survey occurred in both cohorts.
DISCUSSION
Oncology elective courses within the pharmacy
curriculum have been described in literature as increasing
student pharmacists’ interests in oncology pharmacy.
These courses also improve students’ test scores on their
knowledge of oncology and understanding of oncology
practice. However, there are few studies evaluating stu-
dent pharmacists’ confidence and perceptions of oncol-
ogy pharmacy while also assessing knowledge of
oncology and oncology pharmacy practice.6,7 Our study
was conducted to explore student pharmacists’ confi-
dence in and perceptions of oncology pharmacy before
and after completing a four-part interactive activity be-
fore the oncology course and a two-hour session in the
fourth week of the course. These interventions resulted in
significant improvements in scores on several items.
The interactive activity described in this study
allowed students to score levels of confidence in com-
pleting oncology-related tasks and levels of agreement
with oncology practice both pre-course and post-activity.
It served to reinforce concepts in the module and use
practical examples. The activity also provided an oppor-
tunity for students to practice calculations for a com-
pounded chemotherapy product, give recommendations
regarding nonprescription medication use and supportive
care for patients undergoing chemotherapy treatments,
recognize chemotherapy-related drug-drug interactions
and adverse effects, navigate resources to answer ques-
tions posed bymembers of the healthcare team or patients
and family members, and make evidence-based for-
mulary recommendations using knowledge gained in
the oncology module. Implementation of the interac-
tive activity allowed students to apply knowledge, use
critical thinking skills, and answer questions posed in
oncology-related scenarios. Students worked in pre-
assigned groups, which reinforced their teamwork and
communication skills.7 Students experienced a more
realistic environment simulated to represent different
practice settings using a four-station activity.7 The range
of oncology questions asked of the students reflected
real scenarios that oncology pharmacists are expected to
manage and resolve as the scope of their responsibilities
expands.7,8 This activity gave students a true assess-
ment of oncology pharmacy practice in a real-world
application.
Confidence in performing oncology-related activi-
ties increased among students in both cohorts as
Table 1. Demographics of Student Pharmacists Who Participated in a Simulation Activity Intended to Improve Their Knowledge
and Perceptions of Oncology Pharmacy, N533
Cohort 2016 Cohort 2017 p Value
No (%)/Mean (SD) No (%)/Mean (SD)
Gender, No. (%) .81
Male 17 (51.5) 18 (54.5)
Female 16 (48.5) 15 (45.5)
Ethnicity .16
Caucasian 27 (81.8) 18 (54.5)
African American/African 3 (9.1) 7 (21.2)
Hispanic 0 (0) 1 (3.0)
Asian/Pacific Islander 3 (9.1) 4 (12.1)
Other 0 (0) 2 (6.1)
Age 23.3 (1.2) 24.6 (3.1) .04a
Past oncology experience .16
Yes 1 (3.0) 4 (12.1)
No 32 (97.0) 29 (87.9)
a Unpaired t-test was used to determine significance, defined as p,.05, between the two cohorts of student pharmacists
































































evidenced by their responses to all nine questions on the
survey. Student pharmacists’ perceptions of oncology
pharmacists’ roles also improved post-activity for all
questions except one regarding hospital pharmacists be-
ing equipped to answer oncology-related questions at
institutions with a clinical oncology pharmacist. Studies
show that increased perceptions of confidence can lead
to improvements in problem-solving skills and abilities
to make clinical recommendations, which is important
as pharmacists need to be competent in all areas, includ-
ing in oncology.7 Knowledge gaps were identified by
first administering the survey before the interactive ac-
tivity that was intended to reinforce the role and im-
portance of the oncology pharmacist in chemotherapy
management.
Both cohorts of student pharmacists (2016 and 2017)
had similar increases in confidence scores between the
pre- and post-activity survey, which confirms that the
oncology module and interactive activity were delivered
consistently. Students’ perception of the importance of
oncology pharmacists’ roles in practice also improved as
evidenced by responses to all eight questions in fall 2016.
Table 2. Student Pharmacists’ Scores on a Survey Administered Before and After Participating in a Simulation Activity Intended to
Improve Their Knowledge and Perceptions of Oncology Pharmacy
All Cohorts (N=66)
Pretest, median (IQR) Posttest, median (IQR) p Value
Check math on a compounded chemotherapy product. 2 (1-5) 5 (5-6) ,.001a
Make an appropriate OTC recommendation for a cancer
patient undergoing treatment.
2 (1-3) 5 (5-6) ,.001a
Make an appropriate supportive care recommendation or
change for a chemotherapy patient who is
experiencing adverse effects.
2 (1-3) 5 (5-6) ,.001 a
Recognize chemotherapy-related drug-drug interactions. 2 (1-2) 5 (4-5) ,.001 a
Recognize chemotherapy-related adverse effects. 2 (2-3) 6 (5-6) ,.001 a
Navigate resources efficiently to answer chemotherapy-
related questions.
3 (2-4) 6 (5-7) ,.001 a
Answer chemotherapy-related questions asked by other
members of the healthcare team.
2 (1-2) 5 (4-6) ,.001 a
Answer chemotherapy-related questions asked by
patients and their family members.
2 (1-2) 5 (4-6) ,.001 a
Make an evidence-based formulary recommendation on
a chemotherapy agent.
2 (1-3) 5 (5-6) ,.001 a
Community pharmacists should be equipped to answer
oncology-related questions.
6 (5-6) 6 (5-6) .01 a
Hospital pharmacists at institutions without a clinical
oncology pharmacist should be equipped to answer
oncology-related questions.
6 (6-7) 6 (6-7) .01 a
Hospital pharmacists at institutions with a clinical
oncology pharmacist should be equipped to answer
oncology-related questions.
6 (6-7) 6 (6-7) .50
Pharmacists in the managed care setting should be
equipped to make formulary recommendations on
chemotherapy agents.
6 (5-7) 6 (6-7) .007 a
Pharmacists in the managed care setting should be
equipped to answer oncology-related questions about
agents on their formulary.
6 (6-7) 6 (6-7) .16
Oncology impacts areas of pharmacy outside of the
clinical hospital setting.
6 (6-7) 7 (6-7) ,.001 a
Pharmacists play a vital role in the treatment of cancer
patients regardless of their setting.
6 (6-7) 7 (6-7) .002 a
I know what resources to use when searching for the
answer to an oncology-related question.
3 (2-5) 6 (6-7) ,.001 a
7-point Likert type scale (15very unconfident, 75very confident)
a Mann-Whitney-U test was used to compare differences in survey between pre- and post-activity as well as between cohorts
































































This is supported by the literature, as past studies also saw
increases in confidence scores after students completed
oncology elective courses.6-8 However, in fall 2017, the
increase in perceptions and improvement in scores was
less than the prior cohort. Similar results were not seen in
past studies which only reported increases in confidence
and perception scores for all questions.6-8 The oncology
module and interactive activity were administered iden-
tically in both years; therefore, the reason for the decrease
in perception scores in fall 2017 is unclear and warrants
further evaluation in future research.
Both cohorts took the oncology course later in the
third year of the professional program, which may ac-
count for them having identicalmedian confidence scores
both pre- and post-activity. Conducting the interactive
activity at the end of the third year rather than at the be-
ginning of the PharmDprogrammay have been the reason
for the significant increases seen in confidence and
agreement scores from pre- to post-activity. If adminis-
tered earlier in the program, the studentsmay not have had
as much accumulated knowledge and may have had
knowledge deficits prior to the course and lower increases
in scores after the course. However, in a study conducted
by Serag-Bolos and colleagues, both perception questions
only increased by 0.7 and 1.0 points compared to 3 points
in both cohorts examined.7 This may have been because
the content of oncology courses varies at different insti-
tutions. Nonetheless, the elective oncology module and
activity at our institution were ultimately successful in
increasing student confidence and expanding perception
of pharmacists’ involvement in oncology. Pharmacists
being able to perform oncology-related tasks is vital be-
cause of the surge in demand for oncology services. As
experts in pharmacotherapy, pharmacists must know how
to respond to oncology-related questions in order to pro-
vide the best patient care possible.2-4 While not predic-
tive, students deemed to bemore confident and perceptive
in performing these tasks are likely to be more knowl-
edgeable and able to critically think and assess each sit-
uation efficiently and appropriately, which are both
qualities needed for students to become successful phar-
macists.7 All schools of pharmacy should strive to create
oncology modules with an end-goal of increasing student
knowledge accompanied by appropriate confidence and
perceptions.
This study had several limitations. The methods and
resultsmay not be generalizable to all student pharmacists
as it involved third-year student pharmacists. Also, there
was a significant difference in age between the cohorts.
Students in the 2016 cohort were significantly younger
than students in the 2017 cohort, which may have con-
tributed to the greater increases found in confidence
scores in this cohort. Students may have been skewed
more positively due to the belief that survey responses can
influence grades or perceiving that answers given may
need to be acceptable, which may have led to response
bias. However, pre- and post-activity assessments were
created carefully by the module coordinator and a faculty
member with survey experiences and were given at the
beginning of the course and after the interactive activity to
limit confounders. The time between the pre- and post-
activity assessments does not truly inform us about which
components impacted students and whether the impact
was heightened by the activity as this could be due to the
course itself rather than the activity presented. Lastly, this
study only addressed perceptions and not knowledge or
outcomes. Future work should also include administering
knowledge assessments prior to the activity and admin-
istering longitudinal assessments to determine the long-
term impact, particularly in APPEs and in practice.
CONCLUSION
Prior to completing an oncologymodule, two cohorts
of student pharmacists lacked confidence in several areas
of pharmacy practice. Through the implementation of
an interactive oncology activity, student pharmacists’
confidence in their knowledge of oncology pharmaco-
therapy and their perception of oncology pharmacists’
roles in various practice settings increased. Student
pharmacists need to be knowledgeable regarding che-
motherapy regimens as all practice settings expect phar-
macists to be equipped with the tools to respond to any
oncology-related scenarios, regardless of whether an
oncology pharmacist is present. By providing oncology
pharmacotherapy education and developing awareness on
the importance of knowledge and training in oncology
practice through this study, students will be prepared to
practice in any setting to deliver quality patient care as
future pharmacists. This is important, as there is a need for
pharmacists to be oncology-trained to compensate for the
shortage of oncology providers. Implementation of in-
teractive activities can assist faculty in assessing their
oncology module curriculum and whether there needs to
be adjustments in course content in order to allow students
to be successful in oncology-related pharmacy practice.
Interactive oncology activities should be implemented
across all pharmacy schools to increase students’ confi-
dence and knowledge in navigating oncology-related
scenarios on advanced pharmacy practice experiences or
in future career practice settings.
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